AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
prnewswire.com
news
2022-10-20 16:35:00

BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners,Â announced today new senior executive hires to support global growth plans.
International biopharma executive Guillaume Herry has been appointed as CEO, while HR executive Joanne Reichardt has been appointed Head of People & Culture.
AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.
